One Third on First-Line Antiretrovirals have Serious Drug Interaction (Article 11)
HIV Treatment: ALERTS! 2010, Nov
-
- $5.99
-
- $5.99
Publisher Description
About one third of HIV-positive people studied at Albany Medical Center had an important drug-drug interaction involving one of the medications in a first antiretroviral combination that included a protease inhibitor (PI), a nonnucleoside (NNRTI), or the integrase inhibitor Isentress (raltegravir). (1) Drug-drug interactions were more frequent among people taking a PI or an NNRTI than among people taking Isentress. Because of the way drugs are processed in the body, certain medications can greatly raise or lower levels of other drugs taken at the same time. Drugs that have low levels in the body may not work, and drugs that have high levels may cause more side effects or more severe side effects.
GENRE
Business & Personal Finance
RELEASED
2010
November 1
LANGUAGE
EN
English
LENGTH
5
Pages
PUBLISHER
The Center for AIDS: Hope & Remembrance Project
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
61.3
KB
More Books Like This
Ontario Formulary
2005
Iatrogenic Harm Following "HIV" Testing (Report)
2010
Agennix AG Gets Positive Results from Talactoferrin Trial
2010
Solnyx Pharmaceuticals: The Atoxeril Clinical Trial
2005
HIV Tests Are Not HIV Tests.
2010
Cranberry, An Alternative to Antibiotics? Use of Cranberry for Preventing Urinary Tract Infections. A Literature Review/Tranbar, Ett Alternativ Till Antibiotika? en Litteraturstudie Om Tranbar Som Prevention Mot Urinvagsinfektion (Report)
2010